Global Bioactive Coating Devices Market, By Product Type (Hydrophilic Coatings, Anti-Microbial Coatings, Drug Eluting Coating and Others); Material (Carbon-Based Materials, Biological Materials, Polymers and Synthetic and Metals and Alloys); End User (Diagnostics Centers, Hospital, Clinics and Ambulatory Surgical Centers)– Industry Trends and Forecast to 2029
Market Analysis and Size
In order to prevent bacterial adherence and prosthetic infections, these coatings are commonly employed in the fabrication of suitable implantable orthopaedic prosthetic devices. Other bioactive coatings, such as those containing nitric oxide, antibiotics, and silver, are now being researched. Material science and cell biology advancements are major contributors speeding product penetration in developed markets.
Data Bridge Market Research analyses that the bioactive coating devices market which was USD 283.36 million in 2021, would rocket up to USD 560.48 million by 2029, and is expected to undergo a CAGR of 8.90% during the forecast period 2022 to 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2014 - 2019)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Product Type (Hydrophilic Coatings, Anti-Microbial Coatings, Drug Eluting Coating and Others); Material (Carbon-Based Materials, Biological Materials, Polymers and Synthetic and Metals and Alloys); End User (Diagnostics Centers, Hospital, Clinics and Ambulatory Surgical Centers)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
DSM (Netherlands), Hydromer (U.S), SurModics Inc. (U.S), Biocoat Inc. (U.S), AST Products Inc. (U.S), Specialty Coatings Systems Inc. (U.S)
|
|
Market Opportunities
|
|
Market Definition
Bioactive coatings are thin films that are applied to medical devices to prevent bacterial adherence, improve core operation, and add bioactivity and biocompatibility. This is a term that is more typically used in implantable medical devices. Bioactive coatings include bio ceramics, ECM proteins, biological peptides, growth factors, and antimicrobial peptides.
Bioactive Coating Devices Market Dynamics
Drivers
- Improvement in drug loading and delivery
Implantable devices with thin films of bioactive molecules are quickly gaining traction in the treatment fields of cardiology and orthopaedic joint problems, which are currently the two leading causes of loss of quality of life and incapacity. Bioactive molecules are being employed to load and release a large number of material-bound elements to improve drug loading and delivery.
- Rise in diseases
Generic variables such as the rising frequency of systemic joint illnesses, cardiovascular implant and support both a direct result of the world's rapidly ageing population – are fueling global demand for bioactive coating devices.
- Research and development activities
Bioactive coatings in implantable medical devices are being promoted by investments and research in specialist R&D in developed markets, increased academic interest in cell biology, and a greater focus on reducing antimicrobial contamination to limit indiscriminate antibiotic use.
Opportunities
Implantable devices with thin films of bioactive molecules are quickly gaining traction in the treatment fields of cardiology and orthopaedic joint problems, which are currently the two leading causes of loss of quality of life and incapacity. The market for bioactive coating devices is driven by bioactive chemicals and generic variables such as the rising incidence of systemic joint illnesses, cardiovascular implants, and support.
Restraints/Challenges
Barriers to the market for bioactive coating devices include a high likelihood of the bioactive coating losing its effectiveness when it comes into touch with the external physiological environment, a finite reservoir of bioactive chemicals, and a limited number of current uses. Other roadblocks include a lack of research knowledge, a high demand for funding for ongoing research, and a lack of research infrastructure in medium and low-income nations, to name a few.
This bioactive coating devices market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the bioactive coating devices market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Covid-19 Impact on Bioactive Coating Devices Market
Last year, COVID-19 wreaked havoc on the market for bioactive coating devices. The rising danger of infection among the elderly and persons with cardiovascular problems and government limitations on non-essential care reduced hospital visits dramatically. Furthermore, people's socioeconomic conditions around the world have deteriorated, resulting in a significant reduction in healthcare spending in key economies. However, the elimination of COVID restrictions, improved economic growth, and an increase in the number of vaccines are likely to help the business recover quickly and achieve significant growth in the following years.
Global Bioactive Coating Devices Market Scope
The bioactive coating devices market is segmented on the basis of product type, medical application, material and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product type
- Anti-microbial Coatings
- Hydrophilic Coatings
- Drug Eluting Coating
- Others (including Anti-thrombogenic Coatings)
Medical application
- Stents
- Cardiac assist devices
- Electrosurgical tools
- Cochlear and ocular implants
- Mandrels and molds
- Catheters
- Elastomeric seals
- Needles and epidural probes
- Medical electronics
Material
- Biological Materials
- Carbon-Based Materials
- Metals and Alloys
- Polymers and Synthetic
End-user
- Hospital
- Diagnostics Centers
- Ambulatory Surgical Centers
- Clinics
Bioactive Coating Devices Market Regional Analysis/Insights
The bioactive coating devices market is analysed and market size insights and trends are provided by country, product type, medical application, material and end-user as referenced above.
The countries covered in the bioactive coating devices market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominating the market due to high purchasing power.
Asia- Pacific is expected to account for the second largest share in the global market primarily due to low-grade medical devices, which is affected by the high concentrated chemical and adulteration in metals used to prepare the medical devices.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The bioactive coating devices market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for bioactive coating devices market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the bioactive coating devices market. The data is available for historic period 2010-2020.
Competitive Landscape and Bioactive Coating Devices Market Share Analysis
The bioactive coating devices market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to bioactive coating devices market.
Some of the major players operating in the bioactive coating devices market are:
- DSM (Netherlands)
- Hydromer (U.S)
- SurModics Inc. (U.S)
- Biocoat Inc. (U.S)
- AST Products Inc. (U.S)
- Specialty Coatings Systems Inc. (U.S)
SKU-